Genetic pathway-based hierarchical clustering analysis of older adults with cognitive complaints and amnestic mild cognitive impairment using clinical and neuroimaging phenotypes

American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics

Volumn 153, Issue 5, 2010, Pages 1060-1069

  Sloan, Chantel D ^a   Shen, Li ^b   West, John D ^b   Wishart, Heather A ^a   Flashman, Laura A ^a   Rabin, Laura A ^a   Santulli, Robert B ^a   Guerin, Stephen J ^a   Rhodes, C Harker ^a   Tsongalis, Gregory J ^a   McAllister, Thomas W ^a   Ahles, Tim A ^c   Lee, Stephen L ^a   Moore, Jason H ^a,d,e,f   Saykin, Andrew J ^a,b  

^a DARTMOUTH MEDICAL SCHOOL   (United States)

^b INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^d Univ of New Hampshire   (United States)

^e University of Vermont   (United States)

^f TRANSLATIONAL GENOMICS RESEARCH INSTITUTE   (United States)

Author keywords

Alzheimer's disease; Cognitive complaints; Genetics; Imaging; Mild cognitive impairment

Indexed keywords

BETA SECRETASE 1; BETA SECRETASE 2; INTERLEUKIN 6; MULTIDRUG RESISTANCE PROTEIN 1; PRESENILIN 2; PROTEIN BCL 2;

AGED; ALZHEIMER DISEASE; AMNESIA; APBA1 GENE; ARTICLE; BCL2L1 GENE; CASP7 GENE; CHAT GENE; CLUSTER ANALYSIS; COGNITION; COGNITIVE DEFECT; CONTROLLED STUDY; CST3 GENE; DEMENTIA; DRD3 GENE; DRD5 GENE; FEMALE; GENE; GENETIC ASSOCIATION; GENOTYPE; HUMAN; LRP1 GENE; MAJOR CLINICAL STUDY; MALE; MILD COGNITIVE IMPAIRMENT; NAT1 GENE; NEUROIMAGING; NEUROLOGIC EXAMINATION; PHENOTYPE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; ADULT; COGNITION DISORDERS; COMPLICATION; GENETICS; NEUROPSYCHOLOGICAL TEST; NUCLEAR MAGNETIC RESONANCE IMAGING;

ADULT; AGED; ALZHEIMER DISEASE; AMNESIA; CLUSTER ANALYSIS; COGNITION DISORDERS; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; NEUROPSYCHOLOGICAL TESTS; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 77954369067     PISSN: 15524841     EISSN: 1552485X     Source Type: Journal    
DOI: 10.1002/ajmg.b.31078     Document Type: Article

References (65)

1. Almeida OP, Schwab SG, Lautenschlager NT, Morar B, Greenop KR, Flicker L, Wildenauer D. 2008. KIBRA genetic polymorphism influences episodic memory in later life, but does not increase the risk of mild cognitive impairment. J Cell Mol Med 12:1672-1676.
2. Becker KG, Barnes KC, Bright TJ, Wang SA. 2004. The genetic association database. Nat Genet 36:431-432.
3. Bertram L. 2009. Alzheimer's disease genetics current status and future perspectives. Int Rev Neurobiol 84:167-184.
4. Bertram L, Tanzi RE. 2008. Thirty years of Alzheimer's disease genetics: The implications of systematic meta-analyses. Nat Rev Neurosci 9:768-778.
5. Bertram L, McQueen MB, Mullin K, Blacker D, Tanzi RE. 2007. Systematic meta-analyses of Alzheimer disease genetic association studies: The AlzGene database. Nat Genet 39:17-23.
6. Burgess A, Saini S, Weng YQ, Aubert I. 2009. Stimulation of choline acetyltransferase by C3d, a neural cell adhesion molecule ligand. J Neurosci Res 87:609-616.
7. Calissano P, Matrone C, Amadoro G. 2009. Apoptosis and in vitro Alzheimer disease neuronal models. Commun Integr Biol 2:163-169.
8. Chen H, Sharp BM. 2004. Content-rich biological network constructed by mining PubMed abstracts. BMC Bioinformatics 5:147.
9. Cosentino M, Colombo C, Mauri M,Ferrari M, Corbetta S, Marino F, Bono G, Lecchini S. 2009. Expression of apoptosis-related proteins and of mRNA for dopaminergic receptors in peripheral blood mononuclear cells from patients with Alzheimer disease. Alzheimer Dis Assoc Disord 23:88-90.
10. Cuello AC, Bruno MA, Bell KF. 2007. NGF-cholinergic dependency in brain aging, MCI and Alzheimer's disease. Curr Alzheimer Res 4:351-358.
11. Du AT, Schuff N, Chao LL, Kornak J, Jagust WJ, Kramer JH, Reed BR, Miller BL, Norman D, Chui HC, Weiner MW. 2006. Age effects on atrophy rates of entorhinal cortex and hippocampus. Neurobiol Aging 27:733-740.
12. Eisen MB, Spellman PT, Brown PO, Botstein D. 1998. Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci USA 95:14863-14868.
13. Farrer LA, Cupples LA, Haines JL, Hyman B, Kukull WA, Mayeux R, Myers RH, Pericak-Vance MA, Risch N, van Duijn CM. 1997. Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer disease meta analysis consortium. JAMA 278:1349-1356.
14. Fleisher AS, Sowell BB, Taylor C, Gamst AC, Petersen RC, Thal LJ, Alzheimer's Disease Cooperative Study. 2007. Clinical predictors of progression to Alzheimer disease in amnestic mild cognitive impairment. Neurology 68:1588-1595.
15. Galluzzi S, Geroldi C, Benussi L, Ghidoni R, Testa C, Borsci G, Bonetti M, Manfellotto D, Romanelli G, Zulli R, Binetti G, Frisoni GB. 2008. Association of blood pressure and genetic background with white matter lesions in patients with mild cognitive impairment. J Gerontol A Biol Sci Med Sci 63:510-517.
16. Gauthier S, Reisberg B, Zaudig M, Petersen RC, Ritchie K, Broich K, Belleville S, Brodaty H, Bennett D, Chertkow H, Cummings JL, de Leon M, Feldman H, Ganguli M, Hampel H, Scheltens P, Tierney MC, Whitehouse P, Winblad B. 2006. International psychogeriatric association expert conference on mild cognitive impairment. Mild cognitive impairment. Lancet 367:1262-1270.
17. Gorman AM. 2008. Neuronal cell death in neurodegenerative diseases: Recurring themes around protein handling. J Cell Mol Med 12:2263-2280.
18. Grundman M, Jack CR Jr, Petersen RC, Kim HT, Taylor C, Datvian M, Weiner MF, DeCarli C, DeKosky ST, van Dyck C, Darvesh S, Yaffe K, Kaye J, Ferris SH, Thomas RG, Thal LJ, Alzheimer's Disease Cooperative Study. 2003. Hippocampal volume is associated with memory but not monmemory cognitive performance in patients with mild cognitive impairment. J Mol Neurosci 20:241-248.
19. Haass C. 2004. Take five - BACE and the gamma-secretase quartet conduct Alzheimer's amyloid beta-peptide generation. EMBO J 23:483-488.
20. HoA, Liu X, Sudhof TC. 2008. Deletion of mint proteins decreases amyloid production in transgenic mouse models of Alzheimer's disease. J Neurosci 28:14392-14400.
21. Jack CR Jr, Petersen RC, Xu YC,O'Brien PC, Smith GE, Ivnik RJ, Boeve BF, Waring SC, Tangalos EG, Kokmen E. 1999. Prediction of AD with MRI-based hippocampal volume in mild cognitive impairment. Neurology 52:1397-1403.
22. Jack CR Jr, Slomkowski M, Gracon S, Hoover TM, Felmlee JP, Stewart K, Xu Y, Shiung M, O'Brien PC, Cha R, Knopman D, Petersen RC. 2003. MRI as a biomarker of disease progression in a therapeutic trial of milameline for AD. Neurology 60:253-260.
23. Johnson N, Bell P, Jonovska V, Budge M, Sim E. 2004. NAT gene polymorphisms and susceptibility to Alzheimer's disease: Identification of a novel NAT1 allelic variant. BMC Med Genet 5:6.
24. Kanehisa M, Araki M, Goto S, Hattori M, Hirakawa M, Itoh M, Katayama T, Kawashima S, Okuda S, Tokimatsu T, Yamanishi Y. 2008. KEGG for linking genomes to life and the environment. Nucleic Acids Res 36:D480-D484.
25. Kelley BJ, Petersen RC. 2007. Alzheimer's disease and mild cognitive impairment. Neurol Clin 25:577-609, v.
26. Kuhn PH, Marjaux E, Imhof A, De Strooper B, Haass C, Lichtenthaler SF. 2007. Regulated intramembrane proteolysis of the interleukin-1 receptor II by alpha-, beta-, and gamma-secretase. J Biol Chem 282:11982-11995.
27. Kuhnke D, Jedlitschky G, Grube M, Krohn M, Jucker M, Mosyagin I, Cascorbi I, Walker LC, Kroemer HK, Warzok RW, Vogelgesang S. 2007. MDR1-P-glycoprotein (ABCB1) mediates transport of Alzheimer's amyloid-beta peptides - Implications for the mechanisms of abeta clearance at the blood-brain barrier. Brain Pathol 17:347-3353.
28. Lam FC, Liu R, Lu P, Shapiro AB, Renoir JM, Sharom FJ, Reiner PB. 2001. Beta-amyloid efflux mediated by p-glycoprotein. J Neurochem 76:1121-1128.
29. Levenstien MA, Yang Y, Ott J. 2003. Statistical significance for hierarchical clustering in genetic association and microarray expression studies.BMC Bioinformatics 4:62.
30. Lin C, Wang ST, Wu CW, Chuo LJ, Kuo YM. 2003. The association of a cystatin C gene polymorphism with late-onset Alzheimer's disease and vascular dementia. Chin J Physiol 46:111-115. (Pubitemid 37098868)
31. Liu K, Muse SV. 2005. PowerMarker: Integrated analysis environment for genetic marker data. Bioinformatics 2128-2129.
32. Lopez OL, Jagust WJ, Dulberg C, Becker JT, DeKosky ST, Fitzpatrick A, Breitner J, Lyketsos C, Jones B, Kawas C, Carlson M, Kuller LH. 2003. Risk factors for mild cognitive impairment in the cardiovascular health study cognition study: Part 2. Arch Neurol 60:1394-1399. (Pubitemid 37248800)
33. Lu G, Kwong WH, Li Q, Wang X, Feng Z, Yew DT. 2005. Bcl2, bax, and nestin in the brains of patients with neurodegeneration and those of normal aging. J Mol Neurosci 27:167-174.
34. Lukiw WJ, Bazan NG. 2006. Survival signalling in Alzheimer's disease. Biochem Soc Trans 34:1277-1282.
35. Machulda MM, Ward HA, Borowski B, Gunter JL, Cha RH, O'Brien PC, Petersen RC, Boeve BF, Knopman D, Tang-Wai DF, Ivnik RJ, Smith GE, Tangalos EG, Jack CR Jr. 2003. Comparison of memory fMRI response among normal, MCI, and Alzheimer's patients. Neurology 61:500-506.
36. Marcon G, Di Fede G, Giaccone G, Rossi G, Giovagnoli AR, Maccagnano E, Tagliavini F. 2009. A novel Italian presenilin 2 gene mutation with prevalent behavioral phenotype. J Alzheimers Dis 16:509-511.
37. Matsui T, Ramasamy K, Ingelsson M, Fukumoto H, Conrad C, Frosch MP, Irizarry MC, Yuan J, Hyman BT. 2006. Coordinated expression of caspase 8, 3 and 7 mRNA in temporal cortex of Alzheimer disease: Relationship to formic acid extractable abeta 42 levels. J Neuropathol Exp Neurol 65:508-515.
38. McConlogue L, Buttini M, Anderson JP, Brigham EF, Chen KS, Freedman SB, Games D, Johnson-Wood K, Lee M, Zeller M, Liu W, Motter R, Sinha S. 2007. Partial reduction of BACE1 has dramatic effects on Alzheimer plaque and synaptic pathology in APP transgenic mice. J Biol Chem 282:26326-26334.
39. McHugh TL, Saykin AJ, Wishart HA, Flashman LA, Cleavinger HB, Rabin LA, Mamourian AC, Shen L. 2007. Hippocampal volume and shape analysis in an older adult population. Clin Neuropsychol 21:130-145.
40. Michon A. 2009. The concept of mild cognitive impairment: Relevance and limits in clinical practice. Front Neurol Neurosci 24:12-19.
41. Miller CC, McLoughlin DM,Lau KF, Tennant ME, Rogelj B. 2006. The X11 proteins, abeta production and Alzheimer's disease. Trends Neurosci 29:280-285.
42. Monastero R, Camarda C, Cefalu AB, Caldarella R, Camarda LK, Noto D, Averna MR, Camarda R. 2005. No association between the cystatin C gene polymorphism and Alzheimer's disease: A case-control study in an Italian population. J Alzheimers Dis 7:291-295. (Pubitemid 41206940)
43. Nacmias B, Bagnoli S, Tedde A, Cellini E, Guarnieri BM, Bartoli A, Serio A, Piacentini S, Sorbi S. 2006. Cystatin C and apoe polymorphisms in Italian Alzheimer's disease. Neurosci Lett 392:110-113.
44. Nilsen J, Chen S, Irwin RW, Iwamoto S, Brinton RD. 2006. Estrogen protects neuronal cells from amyloid beta-induced apoptosis via regulation of mitochondrial proteins and function. BMC Neurosci 7:74.
45. Papassotiropoulos A, Hock C, Nitsch RM. 2001. Genetics of interleukin 6: Implications for Alzheimer's disease. Neurobiol Aging 22:863-871.
46. Petersen RC, Parisi JE, Dickson DW, Johnson KA, Knopman DS, Boeve BF, Jicha GA, Ivnik RJ, Smith GE, Tangalos EG, Braak H, Kokmen E. 2006. Neuropathologic features of amnestic mild cognitive impairment. Arch Neurol 63:665-672.
47. Pompl PN, Yemul S, Xiang Z, Ho L, Haroutunian V, Purohit D, Mohs R, Pasinetti GM. 2003. Caspase gene expression in the brain as a function of the clinical progression of Alzheimer disease. Arch Neurol 60:369-376.
48. Potkin SG, Guffanti G, Lakatos A, Turner JA, Kruggel F, Fallon JH, Saykin AJ, Orro A, Lupoli S, Salvi E, Weiner M, Macciardi F, for the Alzheimer's Disease Neuroimaging Initiative. 2009. Hippocampal atrophy as a quantitative trait in a genome-wide association study identifying novel susceptibility genes for Alzheimer's disease. PLoS One 4:e6501.
49. Quintanilla RA, Orellana DI, Gonzalez-Billault C, Maccioni RB. 2004. Interleukin-6 induces Alzheimer-type phosphorylation of tau protein by deregulating the cdk5/p35 pathway. Exp Cell Res 295:245-257.
50. R Development Core Team. 2005. R: A language and environment for statistical computing. Vienna, Austria: Foundation for Statistical Computing.
51. Rao DC. 2008. An overview of the genetic dissection of complex traits. Adv Genet 60:3-34.
52. Risacher SL, Saykin AJ, West JD, Shen L, Firpi HA, McDonald BC. Alzheimer's Disease Neuroimaging Initiative (ADNI). 2009. Baseline MRI predictors of conversion from MCI to probable AD in the ADNI cohort. Curr Alzheimer Res 6:347-361.
53. Saito Y, Sano Y, Vassar R, Gandy S, Nakaya T,Yamamoto T, Suzuki T. 2008. X11 proteins regulate the translocation of amyloid beta-protein precursor (APP) into detergent-resistant membrane and suppress the amyloidogenic cleavage of APP by beta-site-cleaving enzyme in brain. J Biol Chem 283:35763-35771.
54. Saykin AJ, Wishart HA, Rabin LA, Santulli RB, Flashman LA, West JD, McHugh TL, Mamourian AC. 2006. Older adults with cognitive complaints show brain atrophy similar to that of amnestic MCI. Neurology 67:834-842.
55. Serretti A, Olgiati P, De Ronchi D. 2007. Genetics of Alzheimer's disease. A rapidly evolving field. J Alzheimers Dis 12:73-92. (Pubitemid 47396303)
56. Shimohama S. 2009. Nicotinic receptor-mediated neuroprotection in neurodegenerative disease models. Biol Pharm Bull 32:332-336.
57. Sorlie T, Tibshirani R, Parker J, Hastie T, Marron JS, Nobel A, Deng S, Johnsen H, Pesich R, Geisler S, Demeter J, Perou CM, Lonning PE, Brown PO, Borresen-Dale AL, Botstein D. 2003. Repeated observation of breast tumor subtypes in independent gene expression data sets. Proc Natl Acad Sci USA 100:8418-8423.
58. Stockley JH, O'Neill C. 2007. The proteins BACE1 and BACE2 and beta-secretase activity in normal and Alzheimer's disease brain. Biochem Soc Trans 35:574-576.
59. Suzuki R, Shimodaira H. 2006. Pvclust: An R package for assessing the uncertainty in hierarchical clustering. Bioinformatics 22:1540-1542.
60. Waldron E, Heilig C, Schweitzer A, Nadella N, Jaeger S, Martin AM, Weggen S, Brix K, Pietrzik CU. 2008. LRP1 modulates APP trafficking along early compartments of the secretory pathway. Neurobiol Dis 31:188-197.
61. Watt JA, Pike CJ, Walencewicz-Wasserman AJ, Cotman CW. 1994. Ultrastructural analysis of beta-amyloid-induced apoptosis in cultured hippocampal neurons. Brain Res 661:147-156. (Pubitemid 2153594)
62. Wilke RA, Mareedu RK, Moore JH. 2008. The pathway less traveled: Moving from candidate genes to candidate pathways in the analysis of genome-wide data from large scale pharmacogenetic association studies. Curr Pharmacogenomics Person Med 6:150-159.
63. Willem M, Lammich S, Haass C. 2009. Function, regulation and therapeutic properties of beta-secretase (BACE1). Semin Cell Dev Biol 20: 175-182.
64. Yamada K, Hashimoto T, Yabuki C, Nagae Y, Tachikawa M, Strickland DK, Liu Q, Bu G, Basak JM, Holtzman DM, Ohtsuki S, Terasaki T, Iwatsubo T. 2008. The low density lipoprotein receptor-related protein 1 mediates uptake of amyloid beta peptides in an in vitro model of the blood-brain barrier cells. J Biol Chem 283:34554-34562.
65. Yu H, Zhang Z, Shi Y, Bai F, Xie C, Qian Y, Yuan Y, Deng L. 2008. Association study of the decreased serum BDNF concentrations in amnestic mild cognitive impairment and the Val66Met polymorphism in Chinese Han. J Clin Psychiatry 69:1104-1111.